Lorenil 200mg

Soft Vaginal Capsules

Composition :

LORENIL 200 mg Soft vaginal capsules Each soft capsule contains: 200 mg fenticonazole nitrate. For the full list of excipients see section 6.1 LORENIL 600 mg Soft vaginal capsules Each soft capsule contains: fenticonazole nitrate 600 mg. For the full list of excipients see section 6.1.

Excipients

Soft vaginal capsules 200 mg: triglycerides of saturated fatty acids; anhydrous colloidal silica. Constituents of the shell: gelatin; glycerol; titanium dioxide; sodium ethyl hydroxybenzoate; sodium propylhydroxybenzoate. Soft vaginal capsules 600 mg: liquid paraffin; white petroleum jelly; soy lecithin; jelly; glycerol; titanium dioxide; sodium ethyl hydroxybenzoate; sodium propylhydroxybenzoate.

Therapeutic indications

Candidiasis of the genital mucous membranes (vulvovaginitis, affected, infectious fluor).

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Dosage

Soft vaginal capsules: 1 soft vaginal capsule of 200 mg in the evening before bedtime for 3 days or according to the judgment of the doctor. 1 vaginal soft capsule of 600 mg in the evening in a single administration. If symptoms persist, a second administration can be repeated after three days. The soft capsules are introduced deeply into the vagina up to the level of the fornixes.

Warnings and Precautions

The use, especially if prolonged, of products for topical use, can give rise to sensitization phenomena. At the time of intravaginal introduction, a modest burning sensation may be found which disappears rapidly.

Interactions

Not known.

Side effects

Lorenil is generally well tolerated on the mucous membranes; only exceptionally mild and transient erythematous reactions have been reported. In case of hypersensitivity reactions or development of resistant microorganisms, treatment should be stopped. Lorenil, in the recommended conditions of use, is only poorly absorbed, therefore systemic repercussions can be excluded.

Pregnancy and breastfeeding

Although the absorption of the drug is poor, the use of Lorenil during pregnancy and lactation is not recommended except in special cases and after a careful evaluation of the benefit / risk ratio by the doctor.